Medical Device Classification

Size: px
Start display at page:

Download "Medical Device Classification"

Transcription

1 Medical Device Classification The Key to Getting a Product on the Market with thanks to... David A. Pettenski, Supervisory Investigation Goals Understand why there is a medical device classification system Identify the medical device classes Understand the differences between regulatory requirements Learn the basic marketing approval process for medical devices How to determine a medical device class U.S. Food & Drug Administration 1 2 Origin of Classification System Medical Device Amendment to the FD&C Act of 1976 May 28, 1976 Provided classification for regulatory purposes A priority of control/oversight Early form of risk based approach Designation of Controls to Mitigate Risk Basis for Classification of Devices Amount of information known about device for intended use & indications for use Scalpel: intended use - cut tissue. Indication in labeling "for making incisions in the cornea". What level of controls are necessary to assure Safety & Effectiveness of device Support or sustain human life OR important in preventing impairment of human health Risk of causing illness or injury 3 4

2 Preamemdment vs Postamendment Devices FD&C Act (Medical Device Amendment May 28, 1976) divided arena of medical devices into either: Preamendment Devices or Postamendment Devices Depending upon when the devices were introduced into commercial distribution Intent to classify all products on the market Pre May 28, 1976 Products Preamendment Device Exempted (with conditions) from marketing clearance Preamendment Status Determinations: Class I and II No 510(k) required Class III No PMA required until called for Marketed with a 510(k) 5 6 Post May 28, 1976 Products Post amendment Device Requires marketing clearance Automatic Class III Introduced onto market after May 1976 Not substantially equivalent to a pre-may 1976 device Not already Classified as I or II Classification Process Establish Panels of Experts by device area FDA refers products to Panels for review Panel Review & Recommendation FDA publish in Federal Register for comments Final Classification Federal Register Code of Federal Regulations 7 8

3 Medical Device Classification & Regulatory Requirements Class I - General Controls (with & w/o exemptions) Class II General Controls and Special Controls (with & w/o exemptions) Class III General Controls and Premarket Approval Class I - General Controls Known information provides reasonable assurance of safety & effectiveness using General Controls OR Known information does not assure S & E, BUT the device Does not support or sustain human life, OR Is not used to prevent impairment of human health AND No unreasonable risk of illness or injury 9 10 General Controls General Controls FD&C Act Section 510 FD&C Act Sec. 510: Registration, Listing, 510(k) FD&C Act Sec. 518: Notification & Other Remedies FD&C Act Sec. 519: Records & Other Reports (MDR, Tracking. Corrections/Removals) Establishment Registration Product Listing 510(k) - Premarket Notification, unless exempt FD&C Act Sec. 520: General Provisions (GMPs/QSR) 11 12

4 General Controls FD&C Act Section 518 General Controls FD&C Act Section 519 Notification Medical Device Reporting Repair, Replace, or Refund Device Tracking (as required) Recall Authority Reports of Removals and Corrections General Controls FD&C Act Section 520 Good Manufacturing Practices/Quality System Regulations, unless exempt Design Controls (as applicable) All class II & III medical devices plus the five class I devices listed in 21 CFR Examples of Class I Devices Examination Gloves 21CFR Dental Hand Instrument 21CFR Elastic Bandages 21CFR Pacemaker Charger 21CFR Ultrasonic Cleaner for Medical Instruments 21CFR Hand-held (Manual) Surgical Instruments 21CFR

5 Class II - Special Controls General Controls alone are insufficient to provide assurance of Safety & Effectiveness BUT Information exists to establish Special Controls Special Controls General Controls + Special Labeling Requirements Performance Standards Postmarket Surveillance Patient Registries Guidelines Recommendations Any other appropriate actions Examples of Class II Devices Cardiac Monitor 21CFR Elbow Joint Metal/Polymer Constrained Cemented Prosthesis 21CFR Pediatric hospital bed 21CFR Infusion Pump 21CFR Powered Wheelchair 21CFR Surgical Drapes 21CFR TENS device 21CFR Class III - Premarket Approval Not enough information to classify as either Class I or II Device usually supports/sustains life, is of substantial importance in preventing impairment of human health or presents a potential, unreasonable risk of illness or injury 19 20

6 Premarket Approval Extensive submission including data showing Safety & Effectiveness Conditions of Approval Annual Reports Examples of Class III Devices Implantable 21CFR Replacement heart valve 21CFR Cranial electrotherapy 21CFR Implanted electrical urinary continence device 21CFR Silicone gel-filled breast implant 21CFR Implanted cerebella stimulator 21CFR Unclassified Device What regulations apply? Similar product for same intended use already on market or is it brand new? Product Classification Database Search: infusion ch.cfm 513(g) Request for Information Request for device status, classification & regulatory requirements applicable to a device Submitted, via mail only. No fees. 60 day response. The 513(g) request should include: A cover letter stating the submission is a 513(g) request. Indicate the contact person's name, address, telephone number and fax number. A detailed description of product/device. A concise Indication(s) for Use Statement. Either proposed labeling or labeling of a marketed similar device. If no labeling is available, note in cover letter

7 513(g) Request for Information Submit the 513(g) request to the following address: 513(g) Coordinator c/o Document Mail Center (HFZ-401) Office of Device Evaluation Center for Devices and Radiological Health 9200 Corporate Boulevard Rockville, MD FDA response to a request for information concerning classification or regulatory requirements is not a "determination" or a classification of a product/device. Classification of a device is accomplished by going through the premarket notification [510(k)] process. Our response to a 513(g) request is our opinion on the device status and regulatory requirements applicable to a product/device. Substantial Equivalence Key element in a 510(k) Establish Equivalence to: A legally marketed device (a predicate*) that does not require a PMA, i.e., a: Preamendments device* A device found by FDA to be Substantially Equivalent (SE), or A reclassified device* *21 CFR (a)(3) Device is Substantially Equivalent (SE) if: In Comparison to a legally marketed device*, it: Has the same intended use, and Has the same technological characteristics as the predicate device, or: Device is Substantially Equivalent (SE) if: Has the same intended use, and Has different technological characteristics and the information in the 510(k): Does not raise new questions of safety and effectiveness, and Demonstrates it is at least as safe and effective as the predicate Approximately 80% are found SE 31 32

8 Device is Not Substantially Equivalent (NSE) if: There is no predicate device Has a new intended use Has different technological characteristics compared to the predicate device and raises a new type question of safety and effectiveness Does not demonstrate that it is at least as safe and effective as the predicate Not Substantially Equivalent (NSE) 2 3% are found NSE Data is looked at last in the 510(k) regulatory process Usually ask for additional information at least once prior to determining the device is NSE for lack of data Finding a Classified Product References A device that delivers an electrical shock for restoring normal heart rhythm: DC-defibrillator Product Classification Database Search m Device Classification Panels 510(k) Premarket Notification Database Search: Lifepak 9 Establishment Registration Database Search: Medtronic ERS Inc Device Listing Database Search: Classify Your Medical Device ( Device Classification Panels ( Medical Device 510(k) and Good Manufacturing Practice (GMP) Exemptions List ( m) 35 36

PHARM 532 Regulation of Pharmaceuticals II

PHARM 532 Regulation of Pharmaceuticals II FDA s Regulatory Structuret PHARM 532 Regulation of Pharmaceuticals II Spring 2009 Center(s) for Biologics Evaluation & Research (CBER) 1 Drug Evaluation & Research (CDER) 2 Device & Radiological Health

More information

fix Menu FDA Pharm 411 Medical Devices Overview of Device Regulations

fix Menu FDA Pharm 411 Medical Devices Overview of Device Regulations fix Pharm 411 Medical Devices Overview of Device Regulations Tom Hazlet Pharmaceutical Outcomes Research & Policy Program unique identifiers for medical products & associated billing issues we don t stock

More information

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation

More information

CBER Regulation of Devices for Cell Therapy

CBER Regulation of Devices for Cell Therapy CBER Regulation of Devices for Cell Therapy Richard D. McFarland, Ph.D., M.D. Associate Director for Policy Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and Research Food

More information

FDA. Design of Biomedical Devices and Systems, 2nd Edition, King & Fries, CRC Press, 2009.

FDA.  Design of Biomedical Devices and Systems, 2nd Edition, King & Fries, CRC Press, 2009. FDA www.fda.gov Design of Biomedical Devices and Systems, 2nd Edition, King & Fries, CRC Press, 2009. ABOUT US FDA's Mission Statement The FDA is responsible for protecting the public health by assuring

More information

MCW Office of Research Standard Operating Procedure

MCW Office of Research Standard Operating Procedure MCW Office of Research Standard Operating Procedure USE AND STORAGE OF INVESTIGATIONAL DEVICES Unit: Applies to: Human Research Protections Program (HRPP), Office of Research MCW Faculty and Staff involved

More information

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011 Draft Guidance for Industry and Food and Drug Administration Staff The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] DRAFT GUIDANCE This guidance document is being

More information

The FDA/CDRH Perspective in the Regulation of Surgical Mesh

The FDA/CDRH Perspective in the Regulation of Surgical Mesh The FDA/CDRH Perspective in the Regulation of Surgical Mesh David Krause, Ph.D., Branch Chief Plastic & Reconstructive Surgery Branch Division of Surgical, Orthopedic & Restorative Devices Office of Device

More information

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices Lisa L. Michels General Counsel & Regulatory Expert Susan J. Schniepp, Distinguished Fellow Regulatory Compliance Associates Inc. U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical

More information

FDA Regulation of Medical Devices

FDA Regulation of Medical Devices Judith A. Johnson Specialist in Biomedical Policy June 25, 2012 CRS Report for Congress Prepared for Members and Committees of Congress Congressional Research Service 7-5700 www.crs.gov R42130 Summary

More information

De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff

De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff Document issued on October 30, 2017. The draft of this document

More information

February 22, Dear Dr. Cox:

February 22, Dear Dr. Cox: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Integra LifeSciences Corp.

More information

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited. Statutory Framework for Devices Medical Devices Investigational Use Application IDE (21 CFR 812) Abbreviated IDE Exempt Pre-Market Approval Applications 510(k) Pre-marketing Notification (21 CFR 807(e))

More information

Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic

Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic This document is scheduled to be published in the Federal Register on 06/14/2018 and available online at https://federalregister.gov/d/2018-12794, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Neurological Devices; Classification of the Evoked Photon Image Capture

Medical Devices; Neurological Devices; Classification of the Evoked Photon Image Capture This document is scheduled to be published in the Federal Register on 09/30/2016 and available online at https://federalregister.gov/d/2016-23633, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Gynecologic

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Gynecologic This document is scheduled to be published in the Federal Register on 06/21/2016 and available online at http://federalregister.gov/a/2016-14627, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Software

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Software This document is scheduled to be published in the Federal Register on 03/06/2019 and available online at https://federalregister.gov/d/2019-04028, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types. Draft Guidance for Industry and

Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types. Draft Guidance for Industry and Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types Draft Guidance for Industry and Food and Drug Administration Staff This guidance document is being distributed

More information

Medical Devices; Neurological Devices; Classification of the Non-Electroencephalogram

Medical Devices; Neurological Devices; Classification of the Non-Electroencephalogram This document is scheduled to be published in the Federal Register on 10/30/2017 and available online at https://federalregister.gov/d/2017-23516, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Dental Devices; Classification of the Auto Titration Device for Oral

Medical Devices; Dental Devices; Classification of the Auto Titration Device for Oral This document is scheduled to be published in the Federal Register on 02/20/2019 and available online at https://federalregister.gov/d/2019-02824, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

AtriCure Inc. Jonathan McElwee Regulatory Affairs Manger 7555 Innovation Way Mason, Ohio 45040

AtriCure Inc. Jonathan McElwee Regulatory Affairs Manger 7555 Innovation Way Mason, Ohio 45040 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure Inc. Jonathan

More information

Disclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs

Disclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs Disclosures FDA Regulation of Laboratory Developed Tests Beaumont Health System, 24 th Annual Symposium on Molecular Pathology September 16, 2015 Roger D. Klein, MD JD Director, Molecular Pathology Clinical

More information

FDA Regulation of Medical Devices

FDA Regulation of Medical Devices Judith A. Johnson Specialist in Biomedical Policy September 14, 2016 Congressional Research Service 7-5700 www.crs.gov R42130 Summary Prior to and since the passage of the Medical Device Amendments of

More information

January 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

January 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service January 3, 2017 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure

More information

External Defibrillator Improvement Initiative

External Defibrillator Improvement Initiative External Defibrillator Improvement Initiative November 2010 Center for Devices and Radiological Health U.S. Food and Drug Administration External Defibrillator Improvement Initiative Table of Contents

More information

IMPROVE THE U.S. MEDICAL DEVICE REGULATORY PATHWAYS

IMPROVE THE U.S. MEDICAL DEVICE REGULATORY PATHWAYS IMPROVE THE U.S. MEDICAL DEVICE REGULATORY PATHWAYS Regulatory & Legislative Policy Levers WISE-AIChE Xiaochen (Denise) Liu BSBE, Bioengineer University of Toledo College of Engineering College of Medicine

More information

510(k) SUMMARY. Masimo Corporation 40 Parker Irvine, CA FAX

510(k) SUMMARY. Masimo Corporation 40 Parker Irvine, CA FAX 510(k) SUMMARY Kon Yq3~ MASIMO JUL 1. 5 2005 4 0 P a rk e, Irvine, CA 92 618 Tel: 949-297-7 000 Fox: 949-2 97-7001 Submitted by: Company Contact: Masimo Corporation 40 Parker Irvine, CA 92618 949-297-7000

More information

510(k) Summary for the Tiger Cannulated Screw System

510(k) Summary for the Tiger Cannulated Screw System 510(k) Summary for the Tiger Cannulated Screw System In accordance with 21 CFR 807.92 of the Federal Code of Regulations the following 510(k) summary is submitted for the Tiger Cannulated Screw System.

More information

Medical Devices; Anesthesiology Devices; Classification of the High Flow Humidified

Medical Devices; Anesthesiology Devices; Classification of the High Flow Humidified This document is scheduled to be published in the Federal Register on 10/26/2018 and available online at https://federalregister.gov/d/2018-23409, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Advanced Surgical Concepts, Ltd. Jonathan Kahan Hogan Lovells US LLP Columbia Square 555 Thirteenth Street, NW Washington, DC 20004

Advanced Surgical Concepts, Ltd. Jonathan Kahan Hogan Lovells US LLP Columbia Square 555 Thirteenth Street, NW Washington, DC 20004 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Advanced Surgical Concepts,

More information

Medical Devices; General and Plastic Surgery Devices; Classification of the Absorbable Lung

Medical Devices; General and Plastic Surgery Devices; Classification of the Absorbable Lung This document is scheduled to be published in the Federal Register on 03/10/2014 and available online at http://federalregister.gov/a/2014-05061, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

ANDREW BALO SENIOR VICE PRESIDENT, REGULATORY, BIOMETRICS, & CLINICAL AFFAIRS DEXCOM, INC 6340 SEQUENCE DRIVE SAN DIEGO, CA 92121

ANDREW BALO SENIOR VICE PRESIDENT, REGULATORY, BIOMETRICS, & CLINICAL AFFAIRS DEXCOM, INC 6340 SEQUENCE DRIVE SAN DIEGO, CA 92121 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 23, 2015 ANDREW

More information

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Closed Loop

Medical Devices; Obstetrical and Gynecological Devices; Classification of the Closed Loop This document is scheduled to be published in the Federal Register on 07/28/2017 and available online at https://federalregister.gov/d/2017-15892, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Ear, Nose, and Throat Devices; Classification of the Active Implantable

Medical Devices; Ear, Nose, and Throat Devices; Classification of the Active Implantable This document is scheduled to be published in the Federal Register on 10/26/2018 and available online at https://federalregister.gov/d/2018-23412, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the This document is scheduled to be published in the Federal Register on 11/07/2017 and available online at https://federalregister.gov/d/2017-24161, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

The Theranos 483s. What can we learn? David Amor, MS, CQA Principal, Medgineering

The Theranos 483s. What can we learn? David Amor, MS, CQA Principal, Medgineering The Theranos 483s. What can we learn? David Amor, MS, CQA Principal, Medgineering www.medgineering.com david@medgineering.com @Medgineering The good. The bad and the ugly. What can we learn? 2006. The

More information

JUN (k) Summary Philips Medical Systems (Cleveland) Inc. "Brilliance Volume" 1. Submitter. 3. Predicate Device Information

JUN (k) Summary Philips Medical Systems (Cleveland) Inc. Brilliance Volume 1. Submitter. 3. Predicate Device Information 510(k) Summary Philips Medical Systems (Cleveland) Inc. "Brilliance Volume" JUN - 6 2006 This summary of this 510(k) provides safety and effectiveness information submitted in accordance with the requirements

More information

FDA identifies this generic type of device as: Absorbable perirectal spacer.

FDA identifies this generic type of device as: Absorbable perirectal spacer. DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Augmenix, Inc. April 1,

More information

510(k) Summary (c) JAN

510(k) Summary (c) JAN 510(k) Summary 807.92(c) JAN 1 6 2009 SPONSOR Company Name Company Address MEDIGARD LIMITED Suite 14A, Tedder Terraces 26-30 Tedder Avenue Main Beach, 4217 Queensland Australia 807.92(a)(1) Telephone 61

More information

Medical Devices; Immunology and Microbiology Devices; Classification of the Automated

Medical Devices; Immunology and Microbiology Devices; Classification of the Automated This document is scheduled to be published in the Federal Register on 10/16/2017 and available online at https://federalregister.gov/d/2017-22305, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Cardiovascular

Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Cardiovascular This document is scheduled to be published in the Federal Register on 07/28/2017 and available online at https://federalregister.gov/d/2017-15901, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Medical Devices; Immunology and Microbiology Devices; Classification of the Nucleic Acid-

Medical Devices; Immunology and Microbiology Devices; Classification of the Nucleic Acid- This document is scheduled to be published in the Federal Register on 10/16/2017 and available online at https://federalregister.gov/d/2017-22287, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays

Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays Draft Guidance for Industry, Clinical Laboratories, and FDA Staff In Vitro Diagnostic Multivariate Index Assays DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document

More information

Medical Devices; Immunology and Microbiology Devices; Classification of Trichomonas

Medical Devices; Immunology and Microbiology Devices; Classification of Trichomonas This document is scheduled to be published in the Federal Register on 08/04/2015 and available online at http://federalregister.gov/a/2015-19072, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

This letter corrects our substantially equivalent letter of November 25, 2014.

This letter corrects our substantially equivalent letter of November 25, 2014. DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 AtriCure Inc., Jonathan

More information

Medical Devices; General and Plastic Surgery Devices; Classification of the Hemostatic Device

Medical Devices; General and Plastic Surgery Devices; Classification of the Hemostatic Device This document is scheduled to be published in the Federal Register on 10/19/2018 and available online at https://federalregister.gov/d/2018-22784, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Regulatory Assessment of Premarket Approval of Medical Devices in US and EU

Regulatory Assessment of Premarket Approval of Medical Devices in US and EU Available online at www.ijpcr.com International Journal of Pharmaceutical and Clinical Research 2017; 9(4): 281-285 doi: 10.25258/ijpcr.v9i04.8534 ISSN- 0975 1556 Research Article Regulatory Assessment

More information

Introduction to the FDA. Historical Context. Changes over Time FDA - BE-200 9/23/2004. Copyright C. S. Tritt, Ph.D. 1

Introduction to the FDA. Historical Context. Changes over Time FDA - BE-200 9/23/2004. Copyright C. S. Tritt, Ph.D. 1 Introduction to the FDA C. S. Tritt, Ph.D. October 21, 2003 Historical Context In the early 1900 s people were being ripped off, made sick and even killed by bad food, patent medicines and cosmetics with

More information

Medical Devices; Immunology and Microbiology Devices; Classification of the Automated

Medical Devices; Immunology and Microbiology Devices; Classification of the Automated This document is scheduled to be published in the Federal Register on 11/14/2017 and available online at https://federalregister.gov/d/2017-24585, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

( ~~~~Proprietary Name - Esremp NE

( ~~~~Proprietary Name - Esremp NE 510O(k) Summary Fy!7 NT] E 4~~~3 OL (0 Z-O FEB 1 7 2010 SPIDENT Co., Ltd. 12, 15 1B-6L. NarndonIgKongDan. Incheon, Korea 405-821 Tel: + 82(32)819-4570 Fax.: -r82(32)819-4572 This summary of 510(k) safety

More information

RE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System

RE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System November 7, 2012 Margaret Hamburg Commissioner Food and Drug Administration Department of Health and Human Services Room 2217 White Oak Building One 10903 New Hampshire Avenue Silver Spring, MD 20993 RE:

More information

April 22, Trilliant Surgical, Limited Mr. J.D. Webb President The Orthomedix Group, Incorporated 1001 Oakwood Boulevard Round Rock, Texas 78681

April 22, Trilliant Surgical, Limited Mr. J.D. Webb President The Orthomedix Group, Incorporated 1001 Oakwood Boulevard Round Rock, Texas 78681 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Trilliant Surgical,

More information

[[Page 63034]] ======================================================================= DEPARTMENT OF HEALTH AND HUMAN SERVICES

[[Page 63034]] ======================================================================= DEPARTMENT OF HEALTH AND HUMAN SERVICES [Federal Register Volume 79, Number 204 (Wednesday, October 22, 2014)] [Rules and Regulations] [Pages 63034-63036] From the Federal Register Online via the Government Printing Office [www.gpo.gov] [FR

More information

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005 Paths to Market & FDA Product Lifecycle Regulation Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005 FDA Organization U.S. Food & Drug Administration Headed by a Commissioner

More information

)Cot Y-9. Atrileu re~ 510(k) Summary JUN General Information. Classification Class 2

)Cot Y-9. Atrileu re~ 510(k) Summary JUN General Information. Classification Class 2 Atrileu re~ )Cot Y-9 510(k) Summary JUN 1 0 2010 General Information Classification Class 2 Trade name Common name Classification Name Manufacturer Contact AtriClip LAA Exclusion System with preloaded

More information

Reducing Unnecessary Medical Imaging Exposure

Reducing Unnecessary Medical Imaging Exposure Reducing Unnecessary Medical Imaging Exposure CDR Sean M. Boyd, MPH, USPHS U.S. Food and Drug Administration Center for Devices and Radiological Health April 30, 2010 Objectives FDA s role in ensuring

More information

Guidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order

Guidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order Guidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order Document issued on: [Level 2, June 15, 2009] This guidance supersedes the document issued under this

More information

Medical Devices; Exemption From Premarket Notification; Class II Devices; Over-the-Counter

Medical Devices; Exemption From Premarket Notification; Class II Devices; Over-the-Counter This document is scheduled to be published in the Federal Register on 03/14/2018 and available online at https://federalregister.gov/d/2018-05116, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

JUN WARNING LETTER

JUN WARNING LETTER DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JUN 2 8 2006 WARNING LETTER Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850 VIA FEDERAL EXPRESS Scott A. Spiro, MD 101 Old

More information

12/3/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota

12/3/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Prof. Angela Panoskaltsis-Mortari s BMEn 5361, 3D Bioprinting The ensemble of science, bioethics, law, regulation,

More information

Navigating the FDA, and understanding Medical Device Preemption. Special Counsel Foulston Siefkin

Navigating the FDA, and understanding Medical Device Preemption. Special Counsel Foulston Siefkin Navigating the FDA, and understanding Medical Device Preemption Presented by Cydney Boler Special Counsel Foulston Siefkin cboler@foulston.com 913-253-2158 March 9, 2010 A bit of Legalese upfront: The

More information

CDRH Device Approval

CDRH Device Approval CDRH Device Approval Mary S. Pastel, ScD Deputy Director for Radiological Health Office of In Vitro Diagnostics and Radiological Health (OIR) Center for Devices and Radiological Health (CDRH) US Food and

More information

Medical Devices; Immunology and Microbiology Devices; Classification of the Brain Trauma

Medical Devices; Immunology and Microbiology Devices; Classification of the Brain Trauma This document is scheduled to be published in the Federal Register on 06/14/2018 and available online at https://federalregister.gov/d/2018-12760, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

ATELIER RÈGLEMENTAIRE DM US/CANADA

ATELIER RÈGLEMENTAIRE DM US/CANADA ATELIER RÈGLEMENTAIRE DM US/CANADA February 19, 2014 Atlanpole Biotherapies 20 février 2014, Angers 2 Overview VCLS A team of seasoned healthcare product developers who advise on product development, and

More information

GE Healthcare Special 510(k) Premarket Notification Submission JUL (k) Summary

GE Healthcare Special 510(k) Premarket Notification Submission JUL (k) Summary Special 510(k) Premarket Notification Submission JUL 21 2010 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: Primary Contact Person: Date: June 23, 2010

More information

Deciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff

Deciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff Deciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff Document issued on October 25, 2017. The draft of this document was issued

More information

US FDA: CMC Issues for INDs

US FDA: CMC Issues for INDs ISBTC Global Regulatory Summit October 29, 2008 US FDA: CMC Issues for INDs Keith Wonnacott, Ph.D. keith.wonnacott@fda.hhs.gov US Food and Drug Administration Center for Biologics Evaluation and Research

More information

Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements

Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements Draft Guidance for Industry

More information

Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE

Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications [510(k)] with Different Technological Characteristics Draft Guidance for Industry and Food and Drug

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES

DEPARTMENT OF HEALTH & HUMAN SERVICES DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -W066-G609 Silver Spring, MD 20993-0002 Lauren Baker, Ph.D. DEC

More information

510(k) Summary JUN K (02R~ 1. General Information 510(k) Owner:

510(k) Summary JUN K (02R~ 1. General Information 510(k) Owner: K (02R~ JUN 22011 510(k) Summary 1. General Information 510(k) Owner: Alpha-Omega Services, Inc. 9156 Rose Street Bellflower, California 90706 Tel: (562) 804-0604 Fax: (562) 804-0610 Contact Person: Bob

More information

May 22, Ranfac Corporation Mr. Christopher Whelan Senior Vice President 30 Doherty Avenue, P.O. Box 635 Avon, Massachusetts 02322

May 22, Ranfac Corporation Mr. Christopher Whelan Senior Vice President 30 Doherty Avenue, P.O. Box 635 Avon, Massachusetts 02322 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Ranfac Corporation Mr.

More information

Software Regulation: The Transfusion Medicine Experience

Software Regulation: The Transfusion Medicine Experience AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin

More information

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014 UNIQUE DEVICE IDENTIFICATION U.S. FDA March 2014 Introduction The Food and Drug Administration (FDA) has released a final rule requiring most medical devices distributed in the United States to carry a

More information

DEC DEPARTMENT OF HEALTH & HUMAN SERVICES

DEC DEPARTMENT OF HEALTH & HUMAN SERVICES DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -W066-G609 Silver Spring, MD 20993-0002 Ms. Victoria Rendon Senior

More information

02../ 5'"3. 510(k) Summary Cod man BACTISEALTM EVD Catheter Sets. Codli1an & Shurtleff, Inc. 325 Paramount Drive Raynham, MA

02../ 5'3. 510(k) Summary Cod man BACTISEALTM EVD Catheter Sets. Codli1an & Shurtleff, Inc. 325 Paramount Drive Raynham, MA ~.. 510Ck) Summary for Codman BACTISEALTM EVD Catheter Sets-Cont.., 'JUL 2 9 2002 ATTACHMENT A K 02../ 5'"3 510(k) Summary Cod man BACTISEALTM EVD Catheter Sets Codli1an & Shurtleff, Inc. 325 Paramount

More information

The Institutional Review Board (IRB) Manual

The Institutional Review Board (IRB) Manual The Institutional Review Board (IRB) Manual Investigational Devices Policy Research that involves the use of investigational devices must conform to Food and Drug Administration (FDA) and Department of

More information

APR Dear Ms. Adair:

APR Dear Ms. Adair: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 2 7 2004 Ms. Kaoru L. Adair Vice President Regulatory Affairs and

More information

Medical Devices; Immunology and Microbiology Devices; Classification of the Next Generation

Medical Devices; Immunology and Microbiology Devices; Classification of the Next Generation This document is scheduled to be published in the Federal Register on 06/22/2018 and available online at https://federalregister.gov/d/2018-13406, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CLINICAL TRIAL

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CLINICAL TRIAL Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline must be read in its

More information

The UDI Experience: From a US Perspective

The UDI Experience: From a US Perspective Simposio Nazionale Bergamo, Italy Saturday 6 May 2017 The UDI Experience: From a US Perspective Lena Cordie Qualitas Professional Services 2017 Qualitas Professional Services, LLC. All rights reserved.

More information

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case 701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers

More information

October 13, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

October 13, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org October 13, 2014 Division of Dockets Management (HFA-305) Food and Drug Administration

More information

November 9, AtriCure, Inc. Jonathan McElwee Regulatory Affairs Manager 7555 Innovation Way Mason, Ohio 45040

November 9, AtriCure, Inc. Jonathan McElwee Regulatory Affairs Manager 7555 Innovation Way Mason, Ohio 45040 November 9, 2018 AtriCure, Inc. Jonathan McElwee Regulatory Affairs Manager 7555 Innovation Way Mason, Ohio 45040 Re: K182565 Trade/Device Name: AtriCure Regulation Number: 21 CFR 882.4250 Regulation Name:

More information

Using Benefit Risk in Making Post Market Decisions. Adam E Saltman MD PhD Medical Officer, FDA CDRH Office of Compliance AFDO 2018

Using Benefit Risk in Making Post Market Decisions. Adam E Saltman MD PhD Medical Officer, FDA CDRH Office of Compliance AFDO 2018 Using Benefit Risk in Making Post Market Decisions Adam E Saltman MD PhD Medical Officer, FDA CDRH Office of Compliance AFDO 2018 Objectives Understand why FDA is interested in the benefit-risk approach

More information

Guidance for Industry, Review Staff, and the Clinical Community

Guidance for Industry, Review Staff, and the Clinical Community Guidance for Industry, Review Staff, and the Clinical Community Guidance on Criteria and Approaches for Postmarket Surveillance Document Issued on: November 2, 1998 U.S. Department of Health and Human

More information

Point-of-Care Cell Processing Devices A Manufacturer s Perspective Clinical trials, regulatory compliance, and commercialization.

Point-of-Care Cell Processing Devices A Manufacturer s Perspective Clinical trials, regulatory compliance, and commercialization. Philadelphia, 2013 Point-of-Care Cell Processing Devices A Manufacturer s Perspective Clinical trials, regulatory compliance, and commercialization. Brian Barnes, Ph.D. VP, Clinical and Regulatory Affairs

More information

Deciding When to Submit a 510(k) for a Change to an Existing Device

Deciding When to Submit a 510(k) for a Change to an Existing Device Deciding When to Submit a 510(k) for a Change to an Existing Device This document is intended to provide guidance in the preparation of a regulatory submission. It does not bind the FDA or the regulated

More information

510(k) Summary NOV

510(k) Summary NOV Acumed Pelvic Bone Plate System K(122538 5 1 0(k) Notification Contact Details 510(k) Summary NOV 19 2012 Applicant Name: Acumed LLC 5885 NW Cornelius Pass Road, Hillsboro, OR 97124-9432 Date Prepared:

More information

Medical Device Regulatory Science: A View from 20 Years at FDA s Device Center

Medical Device Regulatory Science: A View from 20 Years at FDA s Device Center Medical Device Regulatory Science: A View from 20 Years at FDA s Device Center Greg Campbell, Ph.D. President, GCStat Consulting former Director, Division of Biostatistics, CDRH, FDA GCStat@verizon.net

More information

510(k) Summary FF

510(k) Summary FF 510(k) K(091496 Response rnl$2~~~~~~~~~~esir ~~~~~~~November 13, 2009 Page 20 510(k) Summary FF8 232010 (as required per 21ICFR; 807.92) MEP-90 Hair Growth Stimulation System I. Applicant... Midwest RF

More information

Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland

Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland AUT-G0095-1 15 AUGUST 2014 This guide does not purport to be an interpretation of law and/or regulations and is for

More information

Use of Postmarket Data to Support Premarket Approvals

Use of Postmarket Data to Support Premarket Approvals Use of Postmarket Data to Support Premarket Approvals Ken Reali, Clinical Innovations, LLC Liz McOmber, Snell & Wilmer 1 2016 Snell & Wilmer 1 Summary of Premarket Approval (PMA) Premarket approval (PMA)

More information

March 22, Atricure, Inc Mark Job Responsible Third Party Official Regulatory Technology Services, LLC th Street, NW Buffalo, MN 55313

March 22, Atricure, Inc Mark Job Responsible Third Party Official Regulatory Technology Services, LLC th Street, NW Buffalo, MN 55313 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 March 22, 2016 Atricure,

More information

The UDI Experience: From a US Perspective

The UDI Experience: From a US Perspective IRIC Conference Glasgow Scotland Monday 22 August 2016 The UDI Experience: From a US Perspective Lena Cordie Qualitas Professional Services 2016 Qualitas Professional Services, LLC. All rights reserved.

More information

Quality From a Regulatory Reviewer Perspective. UMSEC Summer Software Symposium Assuring Confidence in Predictable Quality of Complex Medical Devices

Quality From a Regulatory Reviewer Perspective. UMSEC Summer Software Symposium Assuring Confidence in Predictable Quality of Complex Medical Devices U. S. Department of Health and Human Services Quality From a Regulatory Reviewer Perspective UMSEC Summer Software Symposium Assuring Confidence in Predictable Quality of Complex Medical Devices July 16,

More information

Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval

Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval Role of the WHO IVD Prequalification Programme in Light of National Regulatory Authority Approval UN Prequalification of Medicines, Diagnostics and Vaccines 6 th Consultative Stakeholder Meeting 4 April

More information

October 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

October 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers

More information

~_Awl (99' ~.,..,~., ~.. FEDERAL EXPRES S. Cahill, Dear Mr.

~_Awl (99' ~.,..,~., ~.. FEDERAL EXPRES S. Cahill, Dear Mr. ~_Awl (99' ~.,..,~., ~.. ~J+ DEPARTMENI.OF HEALTH & HUMAN SERVICES Public Health Serv ice FEDERAL EXPRES S WARNING LETTER Food and Drug Administratio n Center for Devices and 1 ~ ~yy Radiological ~ Health

More information

Overview of the FDA Approval Process for TB Diagnostics

Overview of the FDA Approval Process for TB Diagnostics Overview of the FDA Approval Process for TB Diagnostics Steven Gitterman, M.D., Ph.D. Division of Microbiology Devices Center for Devices and Radiological Health FDA Definition: In Vitro Diagnostic Device

More information